InsiderClue
Insiders · Profile

Levy Adam D.

Chief Financial Officer at Acrivon Therapeutics. Filing since 14 Jan 2026. CIK 0002061876

Company
Date
Role
Action
Shares
Amount
Of holding
ACRV Acrivon Therapeutics, Inc.
4 Aug 2026
Chief Financial Officer
Sold at will
1,142
$1.79K
1.7%
ACRV Acrivon Therapeutics, Inc.
14 Jan 2026
Chief Financial Officer
Bought
8,832
$15.00K
72.7%
2 decisions on file.